Tenax Therapeutics, Inc. (TENX) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Tenax Therapeutics, Inc. (TENX) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

TENX Cash Flow Statement

Tenax Therapeutics, Inc. (TENX) cash flow statement — 30-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-14.15M	-9.31M	-13.41M	-9.15M	-6.26M	-6.97M	-3.53M	-3.09M	-3.03M	-5.17M	-1.17M	-2.08M	-922.97K	-1.72M	-2.31M	-3.33M	-3.43M	-2.94M	-2.77M	-3.02M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-125.93%	-33.62%	-280.35%	-196.54%	-106.63%	-34.86%	-200.29%	-48.35%	-228.4%	-199.5%	49.22%	37.52%	73.1%	41.28%	16.45%	-10.24%	-85.96%	8.8%	-39.3%	-26.66%
Net Income	-17.8M	-15.72M	37.06M	-15.8M	-10.85M	-10.41M	-6.27M	-3.96M	-3.58M	-3.8M	-3.23M	-1.97M	-1.11M	-1.41M	-2.55M	-2.92M	-2.86M	-2.72M	-3.21M	-3.8M
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	4.71K	969	1K	895	29.2K	28.51K	28.01K	27.61K	26.83K	26.27K
Stock-Based Compensation	3.33M	2.84M	-14.37M	5.62M	4.61M	4.14M	0	0	22K	119K	0	0	0	0	0	0	0	0	216.58K	0
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	3.89M	0	-33.44M	0	-1.28M	0	969.1K	20.9K	9K	8K	39.83K	45.26K	56.1K	74.76K	82.73K	86.96K	111.52K	85.66K	99.72K	375.79K
Working Capital Changes	-3.57M	3.57M	-2.67M	1.03M	1.25M	-701K	1.77M	852.27K	513K	-1.49M	2.01M	-155.4K	126.27K	-393.76K	123.79K	-529.84K	-709.71K	-329.41K	98.97K	375.08K
Change in Receivables	0	0	0	0	-1.22M	1.22M	0	0	677.6K	-18K	-648.53K	-96.81K	204.85K	234.8K	0	164.8K	-286.86K	0	124.07K	120.71K
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	449K	305K	432K	5.05M	0	-1.32M	1.61M	1.09M	-221K	-1M	0	0	0	0	529.21K	0	0	183.65K	0	0
Cash from Investing	0	0	0	0	0	0	0	0	0	0	0	0	1.6K	1.24K	4K	0	0	-6.32K	-1.7K	511.54K
Capital Expenditures	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4K	0	0	-6.32K	-1.7K	-1.68K
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	0	0	0	0	0	1.6K	1.24K	0	0	0	0	0	0
Cash from Financing	13.37M	30.5M	11.61M	3.06M	278K	23.56M	67.25K	92.01M	-134K	7.92M	-174.47K	-171.28K	-99.91K	14.01M	626.37K	-91.88K	7.79M	228.76K	0	9.19M
Debt Issued (Net)	0	0	0	0	0	0	-97	-278.8K	0	-88K	-174.47K	-171.28K	-168.16K	-110.4K	624.3K	-91.88K	-136.89K	228.76K	0	0
Equity Issued (Net)	0	30.5M	11.61M	3.06M	278K	23.56M	67.34K	92.29M	-1K	6.52M	0	-282.65K	68.25K	13.9M	2.06K	0	7.93M	0	0	9.19M
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	-1K	0	0	0	0	0	0	0	0	0	0	0
Other Financing	13.37M	0	0	0	0	0	0	0	-133K	1.49M	0	282.65K	0	228.66K	0	0	0	0	0	0
Net Change in Cash	-779K	21.19M	-1.8M	-6.09M	-5.99M	16.6M	-3.46M	88.93M	-3.17M	2.76M	-1.35M	-2.25M	-1.02M	12.29M	-1.68M	-3.42M	4.36M	-2.72M	-2.77M	6.68M
Free Cash Flow	-14.15M	-9.31M	-13.41M	-9.15M	-6.26M	-6.97M	-3.53M	-3.09M	-3.03M	-5.17M	-1.17M	-2.08M	-922.97K	-1.72M	-2.31M	-3.33M	-3.43M	-2.94M	-2.77M	-3.02M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-125.93%	-33.62%	-280.35%	-196.54%	-106.63%	-34.86%	-200.29%	-48.35%	-228.4%	-199.5%	49.13%	37.52%	73.1%	41.41%	16.64%	-10.18%	-85.78%	8.6%	-39.14%	-26.73%
FCF per Share	-0.28	-0.21	-0.34	-0.23	-0.16	-0.19	-0.23	-0.15	-1.55	-4.24	-4.73	-6.98	-3.34	-14.84	-125.55	-202.41	-217.80	-186.87	-215.41	-191.95
FCF Conversion (FCF/Net Income)	0.79x	0.59x	0.86x	0.58x	0.58x	0.67x	0.56x	0.78x	0.85x	1.36x	0.36x	1.06x	0.83x	1.23x	0.91x	1.14x	1.20x	1.08x	0.86x	0.80x
Interest Paid	0	0	0	0	0	0	0	0	9K	8K	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0